Total Clarity Wealth Management’s AstraZeneca AZN Stock Holding History

Total Clarity Wealth Management’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-995	Closed	-$131K	–	278
2022 Q2	$131K	Buy	+995	New	+$131K	0.07%	277
2022 Q1	–	Sell	-85	Closed	-$10K	–	269
2021 Q4	$10K	Hold	85	–	–	﹤0.01%	688
2021 Q3	$10K	Buy	+85	New	+$9.89K	﹤0.01%	669

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Total Clarity Wealth Management's AZN Position: Q3 2022 in Review

Total Clarity Wealth Management sold out of AstraZeneca (AZN) in Q3 2022, closing a stake of 995 shares — an estimated $131K sold.

Total Clarity Wealth Management first reported a position in AZN in Q3 2021 and held it in 3 quarters. The position peaked at $131K in Q2 2022. 965 funds tracked by Wall St. Rank hold AZN as of Q3 2022.

Total Clarity Wealth Management reported no remaining AstraZeneca position as of Q3 2022 after selling out during the quarter.
Total Clarity Wealth Management sold 995 AstraZeneca shares in Q3 2022, an estimated $131K.
Total Clarity Wealth Management first reported a position in AstraZeneca in Q3 2021 and held it in 3 quarters.
Total Clarity Wealth Management's AstraZeneca position peaked at $131K in Q2 2022.
965 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2022.

Based on Total Clarity Wealth Management's 13F filing for Q3 2022, filed 4 Nov 2022.